These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12871083)

  • 1. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
    Weinmann M; Welz S; Bamberg M
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
    De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
    Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumors with hypoxia-activated cytotoxins.
    Ahn GO; Brown M
    Front Biosci; 2007 May; 12():3483-501. PubMed ID: 17485316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hypoxia and its modification of the outcome of radiotherapy.
    Horsman MR; Overgaard J
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i90-i98. PubMed ID: 26983987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of hypoxia-targeting drugs as new cancer chemotherapeutics.
    Nagasawa H; Uto Y; Kirk KL; Hori H
    Biol Pharm Bull; 2006 Dec; 29(12):2335-42. PubMed ID: 17142959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour hypoxia: the picture has changed in the 1990s.
    Brown JM; Giaccia AJ
    Int J Radiat Biol; 1994 Jan; 65(1):95-102. PubMed ID: 7905916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A convenient screening test for hypoxic cell radiosensitizers/cytotoxins.
    Hori H; Yokoyama H; Nagasawa H; Murayama C; Mori T; Yonei S; Satoh T; Inayama S
    Biol Pharm Bull; 1994 Dec; 17(12):1676-8. PubMed ID: 7735218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
    Lawrence YR; Vikram B; Dignam JJ; Chakravarti A; Machtay M; Freidlin B; Takebe N; Curran WJ; Bentzen SM; Okunieff P; Coleman CN; Dicker AP
    J Natl Cancer Inst; 2013 Jan; 105(1):11-24. PubMed ID: 23231975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
    Bache M; Kappler M; Said HM; Staab A; Vordermark D
    Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic advantage of hypoxic cells in tumors: a theoretical study.
    Brown JM; Koong A
    J Natl Cancer Inst; 1991 Feb; 83(3):178-85. PubMed ID: 1988703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel radiation sensitizers targeting tissue hypoxia.
    Rowinsky EK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):61-70. PubMed ID: 10550828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro.
    Sadeghi N; Kok RJ; Bos C; Zandvliet M; Geerts WJC; Storm G; Moonen CTW; Lammers T; Deckers R
    Nanotechnology; 2019 Jun; 30(26):264001. PubMed ID: 30836341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathways: A Novel Approach to Targeting Hypoxia and Improving Radiotherapy Efficacy via Reduction in Oxygen Demand.
    Lin A; Maity A
    Clin Cancer Res; 2015 May; 21(9):1995-2000. PubMed ID: 25934887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of hypoxic tumour cells--clinical experience.
    Overgaard J
    Int J Radiat Biol; 1989 Nov; 56(5):801-11. PubMed ID: 2573679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic radiosensitization: adored and ignored.
    Overgaard J
    J Clin Oncol; 2007 Sep; 25(26):4066-74. PubMed ID: 17827455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.
    Blumenthal RD; Taylor A; Osorio L; Ochakovskaya R; Raleigh JA; Papadopoulou M; Bloomer WD; Goldenberg DM
    Int J Cancer; 2001 Nov; 94(4):564-71. PubMed ID: 11745445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment.
    Graham K; Unger E
    Int J Nanomedicine; 2018; 13():6049-6058. PubMed ID: 30323592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.